Trial Profile
Retrospective study of Adalimumab in patients with active thyroid eye disease (TED)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Graves ophthalmopathy
- Focus Therapeutic Use
- 16 Dec 2015 Status changed from not stated to completed.
- 28 Nov 2015 New trial record